Analytical issues in combinations Tablets [Bioanalytics]

posted by Imran  – Mumbai, 2007-11-03 09:02 (6805 d 08:24 ago) – Posting: # 1270
Views: 4,643

Dear HS and PK Friends

Please suggest

In a BE study of combination tablet A+B, if drug 'A' and drug 'B' has a half life of 2 hrs and 15 hours respectively. Considering sampling upto 5 half life sampling for drug 'A' will be up to 12 hrs and that of drug 'B' will be up to 75 hrs to capture at least 80% AUC.

My question is ' if I analysed drug 'A' only upto 12 hrs and drug 'B'upto 75 hrs to save the analysis of drug 'A' which own be of any use for analysing upto 75 hrs, will it be acceptable from regulatory point of view.

best regards,

Dr.Imran Khan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
151 visitors (0 registered, 151 guests [including 39 identified bots]).
Forum time: 18:26 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5